Approval · Notice of Compliance 29361 · 2022
ELIGARD: Notice of Compliance 29361
Issued November 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29361
- Date
- November 1, 2022
- Company
- Tolmar International Ltd.Dublin, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the Product Monograph to the 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELIGARD | Not yet assigned | — |
Medicinal ingredients
- LEUPROLIDE ACETATE 7.5 MG per SYR
- LEUPROLIDE ACETATE 22.5 MG per SYR
- LEUPROLIDE ACETATE 30 MG per SYR
- LEUPROLIDE ACETATE 45 MG per SYR